Omkar Kawalekar

Senior Manager, Eminence Lead, NextGen Therapies at Deloitte Consulting

Speaker

Omkar Kawalekar is a recognized leader in the Cell and Gene Therapy (CGT) industry with over 15 years of experience, specializing in the manufacturing, supply chain, and commercialization of these advanced therapies. As a co-founder of Deloitte’s NextGen Therapies consulting practice, Omkar has played a pivotal role in shaping the industry, by working with emerging biotechs as well as established biopharma companies in bringing these complex therapies to patients globally. He leads Eminence at Deloitte, regularly contributing thought-leadership and speaking at global conferences. Omkar earned his PhD under Dr. Carl June at the University of Pennsylvania, where he focused on the bio-mechanisms of CAR-T cell expansion and anti-tumor activity.